[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Nugrahani et al., 2020 - Google Patents

Composing novel diclofenac potassium and l-proline salt cocrystal as a strategy to increase solubility and dissolution

Nugrahani et al., 2020

Document ID
15333295119045906968
Author
Nugrahani I
Komara S
Horikawa A
Uekusa H
Publication year
Publication venue
Journal of Pharmaceutical Sciences

External Links

Snippet

This research dealt with the multicomponent crystal developed from diclofenac potassium and l-proline to improve the pharmaceutical performance of this anti-inflammatory drug. Slow evaporation of the component mixture at a 1: 1 M ratio, supported by ultrasonication …
Continue reading at www.sciencedirect.com (other versions)

Similar Documents

Publication Publication Date Title
Nugrahani et al. Composing novel diclofenac potassium and l-proline salt cocrystal as a strategy to increase solubility and dissolution
Park et al. Emodin-nicotinamide (1: 2) cocrystal identified by thermal screening to improve emodin solubility
Fucke et al. How good are the crystallisation methods for co-crystals? A comparative study of piroxicam
Deng et al. Dapagliflozin-citric acid cocrystal showing better solid state properties than dapagliflozin
ES2309090T3 (en) SALTS OF VALSARTAN.
Zhang et al. Thermodynamics and crystallization of a theophylline–salicylic acid cocrystal
Chun et al. Characteristics of indomethacin–saccharin (IMC–SAC) co-crystals prepared by an anti-solvent crystallization process
Caira et al. Co-crystals of the antiretroviral nevirapine: crystal structures, thermal analysis and dissolution behaviour
Wang et al. 2: 1 5-Fluorocytosine–acesulfame CAB cocrystal and 1: 1 5-fluorocytosine–acesulfame salt hydrate with enhanced stability against hydration
Khatioda et al. Solubility and in vitro drug permeation behavior of ethenzamide cocrystals regulated in physiological pH environments
Chen et al. Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid
Abourahma et al. Examining the robustness of a theophylline cocrystal during grinding with additives
Perumalla et al. Robust bulk preparation and characterization of sulfamethazine and saccharine salt and cocrystal polymorphs
Grepioni et al. Ionic co-crystals of racetams: solid-state properties enhancement of neutral active pharmaceutical ingredients via addition of Mg 2+ and Ca 2+ chlorides
Khanfar et al. Preparation and evaluation of co-amorphous formulations of telmisartan—amino acids as a potential method for solubility and dissolution enhancement
Lemmerer et al. Synthesis characterization molecular modeling of a pharmaceutical co-crystal:(2-chloro-4-nitrobenzoic acid):(nicotinamide)
Li et al. Discovered two polymorphs and two solvates of lamotrigine-tolfenamic acid salt: Thermal behavior and crystal morphological differences
Li et al. Multicomponent crystals of clotrimazole: A combined theoretical and experimental study
Xia et al. Rucaparib cocrystal: Improved solubility and bioavailability over camsylate
Friščić et al. A rational approach to screen for hydrated forms of the pharmaceutical derivative magnesium naproxen using liquid-assisted grinding
Li et al. Eutectics and salt of dapsone with hydroxybenzoic acids: binary phase diagrams, characterization and evaluation
Chen et al. A novel soluble lornoxicam-sodium chelate monohydrate with improved plasticity and tabletability
WO2015007206A1 (en) Afatinib acid addition salts and crystal forms thereof, preparation method and pharmaceutical composition thereof
Samipillai et al. Co-amorphous solids of dasatinib and olanzapine by saccharin with promising physicochemical properties
Nugrahani et al. Theophylline-Na-sacharrine single crystal isolation for its structure determination